🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Status
Not Yet Recruiting
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2024-04-30
Trial ID
NCT06370754
For limited-stage small cell lung cancer (SCLC), neoadjuvant chemotherapy p...
Status
Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-04-01
Trial ID
NCT06256237
Treatments Being Tested
The objective of this study is to evaluate the efficacy and safety of chemo...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07101614
The primary objective is to assess the safety and tolerability of TAB004 as...
Status
Unknown
Location
University of Alabama at Birmingham
Start Date
2019-10-30
Trial ID
NCT04137900
Treatments Being Tested
An open-label, dose-escalation, phase I clinical study to evaluate the safe...
Status
Completed
Location
Fujian Provincial Cancer Hospital
Start Date
2021-04-12
Trial ID
NCT04773951
A First-in-human, dose-escalation, dose-expansion phase I clinical study of...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2020-07-17
Trial ID
NCT04477772
This is an open-label phase I study to evaluate the safety, tolerability, a...
Status
Terminated
Location
Chinese PLA General Hospital
Start Date
2022-07-28
Trial ID
NCT05427396
Treatments Being Tested
For stage III non-small cell lung cancer (NSCLC), neoadjuvant chemotherapy ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05891080
Treatments Being Tested
A 3-part (dose-escalation, dose-expansion and cohort-expansion) phase I cli...
Status
Completed
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2020-04-28
Trial ID
NCT04278859
A phase I/II clinical study of JS004 in subjects with head and neck cancer ...
Status
Completed
Location
Sichuan Cancer Hospital
Start Date
2021-05-11
Trial ID
NCT04929080